UK markets closed

Novozymes A/S (NZM2.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
54.98-0.52 (-0.94%)
At close: 09:43PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
3,024,000
3,024,000
3,676,000
3,146,000
2,825,000
-
Depreciation & amortisation
1,389,000
1,389,000
1,457,000
1,374,000
1,266,000
-
Stock-based compensation
151,000
151,000
127,000
78,000
54,000
-
Change in working capital
-166,000
-166,000
-583,000
-612,000
311,000
-
Inventory
138,000
138,000
-787,000
-556,000
181,000
-
Other working capital
2,096,000
2,096,000
1,116,000
2,822,000
3,415,000
-
Other non-cash items
-5,000
-5,000
-55,000
34,000
175,000
-
Net cash provided by operating activities
4,152,000
4,152,000
4,006,000
4,062,000
4,355,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,056,000
-2,056,000
-2,890,000
-1,240,000
-940,000
-
Acquisitions, net
-
-
-
-1,631,000
-588,000
-
Purchases of investments
-
-
-
-
-
0
Net cash used for investing activities
-2,133,000
-2,133,000
-2,672,000
-2,747,000
-1,524,000
-
Net change in cash
130,000
130,000
84,000
-271,000
517,000
-
Cash at beginning of period
1,041,000
1,041,000
963,000
1,181,000
711,000
-
Cash at end of period
1,116,000
1,116,000
1,041,000
963,000
1,181,000
-
Free cash flow
Operating cash flow
4,152,000
4,152,000
4,006,000
4,062,000
4,355,000
-
Capital expenditure
-2,056,000
-2,056,000
-2,890,000
-1,240,000
-940,000
-
Free cash flow
2,096,000
2,096,000
1,116,000
2,822,000
3,415,000
-